Determination of non-IgE antibodies and expression of cytokine and FoxP3 genes in asthma
DOI:
https://doi.org/10.56294/sctconf2023500Keywords:
Asthma, Antibodies, CytokinesAbstract
Introduction: the inflammatory cascade in asthma involves cells of the innate and adaptive response of the immune system, in addition to molecular mediators such as antibodies, cytokines, chemokines, and costimulatory and regulatory signals corresponding to each of the cellular subpopulations that orchestrate this process.
Objective: to determine the concentration of IgA, IgM and IgG antibodies and the expression of cytokine genes TNFα, IFNγ, TGF-β 1, IL-10, IL-1 α, IL-1β and IL-6 and transcription factor FoxP3 in blood mononuclear cells stimulated in vitro, case-control studies were carried out in asthmatic children and adults respectively.
Methods: the study was conducted in Pinar del Río, Cuba, from 2015 to 2019. Samples were taken from 735 asthmatic children for antibody quantification. For the expression of cytokine genes, samples were taken from 18 adults from the Immunology clinic.
Results: significant differences were found in increasing order of IgM, IgA and IgG antibodies in favor of asthmatic children; and lower values of cytokine and FoxP3 expression in adult asthmatics. A predominance of a Th1 pattern was observed in controls compared to asthmatics, where the latter's predisposition to a Th2 response pattern is known. Therefore, the lower expression of non-Th2 cytokine genes suggests complex cellular and molecular interactions in asthmatic adults.
Conclusions: a lower expression of cytokines other than Th2 was evident in the blood mononuclear cells of adult asthmatics.
References
1. Díaz Amor P. Origen e historia natural del asma. Rev Chil Enferm Respir 2019;35:169-72.
2. GEMA. Guía española para el manejo del asma. Madrid: Luzan5; 2019.
3. Kalchiem-Dekel O, Yao X, Levine SJ. Meeting the Challenge of Identifying New Treatments for Type 2-Low Neutrophilic Asthma. CHEST 2020;157:26-33. https://doi.org/10.1016/j.chest.2019.08.2192.
4. Castillo OO, Sánchez MAL, Castillo MO, Ferrer RL, Valdés CAM. Modelo de regresión logística binaria para el cálculo de riesgo de asma en Pinar del Río. Rev Cienc Médicas Pinar Río 2021;25:5301.
5. Castillo OO, Castillo MO, Ferrer RL, Hernández AL, Sixto DB, Corrales SG. Exploración epidemiológica de la contribución materna y paterna en el asma en Pinar del Río. Rev Cienc Médicas Pinar Río 2022;26:5450.
6. Sze E, Bhalla A, Nair P. Mechanisms and therapeutic strategies for non ‐ T2 asthma. Allergy 2020;75:311-25. https://doi.org/10.1111/all.13985.
7. Gómez-Bastero A, Serra J. Inmunoterapia en asma. Rev Asma 2019;4:26-30.
8. Abbas A, Lichtman A, Pillai S. Cellular and Molecular Immunology. 9th ed. Elsevier; 2018.
9. Choy DF, Arron JR. Beyond type 2 cytokines in asthma - new insights from old clinical trials. Expert Opin Ther Targets 2020;24:463-75. https://doi.org/10.1080/14728222.2020.1744567.
10. Punt J, Stranford S, Jones P, Owen J. Kuby Immunology. 8th ed. Mc Graw-Hill/Interamericana Editores, S.A. de C.V.; 2019.
11. Gómez-Tejeda JJ, Dieguez-Guach RA, Tamayo-Velázquez O, Iparraguirre-Tamayo AE, Perez-Abreu MR. Intervención educativa sobre la medicina natural y tradicional como terapéutica en el asma bronquial. Univ Médica Pinareña 2020;17:609.
12. Jonsson S, Sveinbjornsson G, De Lapuente Portilla AL, Swaminathan B, Plomp R, Dekkers G, et al. Identification of sequence variants influencing immunoglobulin levels. Nat Genet 2017;49:1182-91. https://doi.org/10.1038/ng.3897.
13. Frigolet M, Gutiérrez Aguilar R. Ciencias “ ómicas ”, ¿ cómo ayudan a las ciencias de la salud? Rev Digit Univ 2017;18:0-15.
14. Lin S, Shi L, Ye Y. Advanced Molecular Knowledge of Therapeutic Drugs and Natural Products Focusing on Inflammatory Cytokines in Asthma. cells 2019;8:1-24.
15. Guiddir T, Saint-Pierre P, Purenne-Denis E, Lambert N, Laoudi Y. Neutrophilic Steroid-Refractory Recurrent Wheeze and Eosinophilic Steroid-Refractory Asthma in Children. 2017. https://doi.org/10.1016/j.jaip.2017.02.003.
16. Osquel A, Madruga EA. Repercusión social de los métodos para el tratamiento preventivo en las enfermedades alérgicas. Rev Cuatrimest “Conecta Lib 2018;2:1-12.
17. Kim J, Ye Y, Ban G, Shin Y, Lee HY, Nam Y, et al. Effects of Immunoglobulin Replacement on Asthma Exacerbation in Adult Asthmatics with IgG Subclass Deficiency. Allergy Asthma Immunol Res 2017;9:526-33.
18. Sugimoto M, Kamemura N, Nagao M, Irahara M, Kagami S, Fujisawa T, et al. Differential response in allergen-specific IgE , IgGs , and IgA levels for predicting outcome of oral immunotherapy. Pediatr Allergy Immunol 2016;27:276-82. https://doi.org/10.1111/pai.12535.
19. Doorley LA, Lemessurier KS, Iverson AR, Palipane M. Immunobiology Humoral immune responses during asthma and in fl uenza co-morbidity in mice. Immunobiology 2017:0-1. https://doi.org/10.1016/j.imbio.2017.08.002.
20. Mizhiritskaya T V, Galyna Y, Nation- K. State of humoral immunity in patients with asthma combined with obesity. INTER COLLEGAS 2017;4:123-7.
21. Lahoda D, Velychko V. Dynamics of changes in the level of IgA in patients with bronchial asthma against the background of excessive body weight or obesity. Eur J Clin Exp Med 2019;17:203-8. https://doi.org/10.15584/ejcem.2019.3.1.
22. Muñoz-López F. Asthma: endotypes and phenotypes at a pediatric age Asma: endotipos y fenotipos en la edad pediátrica. Rev Alerg México 2019;66:361-5. https://doi.org/10.29262/ram.v66i3.596.
23. Falcón-Rodríguez CI, Rosas-Pérez I, Segura-Medina P. Relación de los mecanismos inmunológicos del asma y la contaminación ambiental. Rev Fac Med 2017;65:333-42. https://doi.org/10.15446/revfacmed.v65n2.59954.
24. Martínez Ramos S. Estudio de las inmunoglobulinas séricas en pacientes pediátricos con bronquitis crónica y recurrente y/o asma. Universidad de Cádiz, 2020.
25. Pita Rodriguez G, Molina Esquivel E, Christian López L, Monterrey Gutiérrez P. Asociaciones entre concentraciones de inmunoglobulinas en niños, factores ambientales de riesgo y morbilidad respiratoria. Rev Cuba Hig Epidemiol 2001;39:101-9.
26. Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol 2015;16:45-56. https://doi.org/10.1038/ni.3049.
27. Lambrecht BN, Hammad H, Fahy J V. The Cytokines of Asthma. Immunity 2019;50:975-91. https://doi.org/10.1016/j.immuni.2019.03.018.
28. Narendra D, Blixt J, Hanania NA. Seminars in Immunology Immunological biomarkers in severe asthma. Semin Immunol 2019;46:10. https://doi.org/10.1016/j.smim.2019.101332.
29. Halwani R, Sultana A, Vazquez-Tello A, Jamhawi A, Al-Masri AA, Al-Muhsen S. Th-17 regulatory cytokines IL-21, IL-23, and IL-6 enhance neutrophil production of IL-17 cytokines during asthma. J Asthma 2017;54:893-904. https://doi.org/10.1080/02770903.2017.1283696.
30. Rothers J, Stern DA, Lohman IC, Spangenberg A, Wright AL, Devries A, et al. Maternal Cytokine Pro fi les during Pregnancy Predict Asthma in Children of Mothers without Asthma. Am J Respir Cell Mol Biol 2018;59:592-600. https://doi.org/10.1165/rcmb.2017-0410OC.
31. Al-Ghamdi BR, Koshak EA, Omer FM, Awadalla NJ. Immunological Factors Associated with Adult Asthma in the Aseer Region , Southwestern Saudi Arabia. Int J Environ Res Public Health 2019;16:1-12.
32. Nguyen-Thi-Dieu T, Le-Thi-Thu H, Le-Thi-Minh H, Pham-Nhat A, Duong-Quy S. Study of Clinical Characteristics and Cytokine Profiles of Asthmatic Children with Rhinovirus Infection during Acute Asthma Exacerbation at National Hospital of Pediatrics. Can Respir J 2018;2018:8. https://doi.org/10.1155/2018/9375967.
33. Teixeira LK, Fonseca BPF, Barboza BA, Viola JPB. The role of interferon- γ on immune and allergic responses. Mem Inst Oswaldo Cruz 2005;100:137-44.
34. Bai Ya, Zhou Q, Fang Q, Song L, Chen K. Inflammatory Cytokines and T-Lymphocyte Subsets in Serum and Sputum in Patients with Bronchial Asthma and Chronic Obstructive Pulmonary Disease. Med Sci Monit 2019:2206-10. https://doi.org/10.12659/MSM.913703.
35. Kuruvilla ME, Lee FE-H, Lee GB. Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease. Clin Rev Allergy Immunol 2019;56:219-33. https://doi.org/10.1007/s12016-018-8712-1.Understanding.
36. Lachowicz-Scroggins ME, Dunican E, Charbit A, Raymond W, Looney M, Peters M. Extracellular Dna, Neutrophil Extracellular Traps, and Inflammasome Activation in Severe Asthma. Am J Respir Crit Care Med 2019:1-37.
37. Ray A, Kolls JK. Neutrophilic Inflammation in Asthma and Association with Disease Severity. Trends Immunol 2017;38:942-54. https://doi.org/10.1016/j.it.2017.07.003.
38. Thibeault A-AH, Laprise C. Cell-Specific DNA Methylation Signatures in Asthma. Genes 2019;10:2-26.
39. Chu DK, Al-Garawi A, Llop-Guevara A, Pillai RA, Radford K, Shen P, et al. Therapeutic potential of anti-IL-6 therapies for granulocytic airway inflammation in asthma. Allergy Asthma Clin Immunol 2015;11:1-6. https://doi.org/10.1186/s13223-015-0081-1.
40. González Galván MA. Factores genéticos compartidos entre la obesidad y el asma. Univesidad de La Laguna, 2019.
41. Hasegawa K, Tsugawa Y, Chang Y, Camargo CA. Risk of an asthma exacerbation after bariatric surgery in adults. J Allergy Clin Immunol 2015;136:288-294.e8. https://doi.org/10.1016/j.jaci.2014.12.1931.
42. Hsiao HP, Lin MC, Wu CC, Wang CC, Wang TN. Sex-Specific Asthma Phenotypes, Inflammatory Patterns, and Asthma Control in a Cluster Analysis. J Allergy Clin Immunol Pract 2019;7:556-567.e15. https://doi.org/10.1016/j.jaip.2018.08.008.
43. Van Huisstede A, Rudolphus A, Cabezas MC, Biter LU, Van De Geijn GJ, Taube C, et al. Effect of bariatric surgery on asthma control, lung function and bronchial and systemic inflammation in morbidly obese subjects with asthma. Thorax 2015;70:659-67. https://doi.org/10.1136/thoraxjnl-2014-206712.
44. Soya VL, Lezana VN, Silva AP. Obesidad infantil y asma bronquial. Neumol Pediatr 2019;14:200-4.
45. Babusikova E, Jurecekova J, Jesenak M, Evinova A. Asociación entre polimorfismos genéticos de la interleucina 6 y el asma bronquial en niños. Arch Bronconeumol 2017;53:381-6. https://doi.org/10.1016/j.arbres.2016.09.012.
Published
Issue
Section
License
Copyright (c) 2023 Odalys Orraca-Castillo, Tatiana Margarita Blanco Valdés, Ana Beatriz Pérez Díaz, Beatriz Sierra Vázquez, Carlos Alfredo Miló-Valdés (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
